A novel set of thiazolylhydrazonothiazoles bearing an
indole moiety
were synthesized by subjection reactions of carbothioamide derivative
and hydrazonoyl chlorides (or α-haloketones). The cytotoxicity
of the synthesized compounds was evaluated against the colon carcinoma
cell line (HCT-116), liver carcinoma cell line (HepG2), and breast
carcinoma cell line (MDA-MB-231), and demonstrated encouraging activity.
Furthermore, when representative products were assessed for toxicity
against normal cells, minimal toxic effects were observed, indicating
their potential safety for use in pharmacological studies. The mechanism
of action of the tested products, as inhibitors of the epidermal growth
factor receptor tyrosine kinase domain (EGFR TK) protein, was suggested
through docking studies that assessed their binding scores and modes,
in comparison to a reference standard (W19), thus endorsing their
anticancer activity.